Finalists announced for NIH's RADx® Tech Fetal Monitoring Challenge - CIMIT MAIN
Programs and Offerings
NIH awards interim prizes in fetal diagnostic and monitoring technology competition
The National Institutes of Health has announced the finalists in its competition to accelerate the development of diagnostic and monitoring technologies to improve fetal health outcomes focusing on low-resource settings.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Bill & Melinda Gates Foundation partnered to launch the RADx® Tech Fetal Monitoring Challenge in September 2023. The multi-phased competition aims to address the causes of fetal morbidity and mortality, including the estimated 2 million incidences of stillbirth that occur globally each year, with over 24,000 that occur in the United States alone. Novel and accessible technologies are needed to enable earlier and more accurate diagnosis, detection, and monitoring of fetal health status.
News and Events
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Connect with Us
Our Lasting Impact
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.